CD8A and neoplasm: Furthermore, we found that the mechanism by which hexanoate enhances the anti‐tumor immune response involves quashing the Treg‐mediated immunosuppression of CD8+ T cells, thereby indirectly enhancing the intratumoral infiltration and effector function of CD8+ T cells.